Insights from the IPF-PRO Registry. Read Article Category: NewsBy Murali RamaswamyJuly 30, 2019Post navigationPreviousPrevious post:PulmonIx wins 5 star patient care awardNextNext post:A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary FibrosisRelated PostsEffect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary FibrosisMarch 30, 2023September is Pulmonary Fibrosis Awareness Month #PFAM2022 and #BlueUpForPFSeptember 26, 2022Importance of Clinical TrialsAugust 26, 2022Cone Health Medical Staff Honors Its ‘Health Care Heroes’October 6, 2021
Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary FibrosisMarch 30, 2023